Yesim Eralp

Summary

Publications

  1. ncbi request reprint MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer
    Y Eralp
    Department of Medical Oncology, Institute of Oncology, Istanbul University, Topkapi, 34390 Istanbul, Turkey
    Ann Oncol 19:669-74. 2008
  2. ncbi request reprint Leptomeningeal dissemination of ovarian carcinoma through a ventriculoperitoneal shunt
    Yesim Eralp
    Istanbul University, Institute of Oncology, Department of Medical Oncology, Topkapi, Istanbul 34390, Turkey
    Gynecol Oncol 108:248-50. 2008
  3. pmc Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
    Yesim Eralp
    Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Breast Cancer Res 6:R275-83. 2004
  4. ncbi request reprint Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group
    Yesim Eralp
    Institute of Oncology, University of Istanbul, Capa, Topkapi 34390, Istanbul, Turkey
    Cancer Invest 21:737-43. 2003
  5. ncbi request reprint Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix
    Y Eralp
    Department of Medical Oncology, University of Istanbul, Institute of Oncology, Istanbul, Turkey
    Int J Gynecol Cancer 13:497-504. 2003
  6. doi request reprint Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger
    Yesim Eralp
    Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA
    J Cancer Res Clin Oncol 135:141-8. 2009
  7. doi request reprint Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer
    Duygu Derin
    Department of Medical Oncology, Institute of Oncology, Istanbul University
    Cancer Invest 26:671-9. 2008
  8. doi request reprint Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Yesim Eralp
    Department of Medical Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey
    Am J Clin Oncol 36:215-23. 2013
  9. ncbi request reprint Factors related to recurrence after pathological complete response to postoperative chemotherapy in patients with epithelial ovarian cancer
    Hakan Karagol
    Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
    Tumori 95:207-11. 2009
  10. ncbi request reprint Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istanbul, Turkey
    Am J Clin Oncol 25:502-8. 2002

Detail Information

Publications34

  1. ncbi request reprint MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer
    Y Eralp
    Department of Medical Oncology, Institute of Oncology, Istanbul University, Topkapi, 34390 Istanbul, Turkey
    Ann Oncol 19:669-74. 2008
    ..The aim of this study is to evaluate the prognostic impact of various molecular factors in patients with triple-negative breast cancer...
  2. ncbi request reprint Leptomeningeal dissemination of ovarian carcinoma through a ventriculoperitoneal shunt
    Yesim Eralp
    Istanbul University, Institute of Oncology, Department of Medical Oncology, Topkapi, Istanbul 34390, Turkey
    Gynecol Oncol 108:248-50. 2008
    ..This report describes an unusual case with iatrogenic leptomeningeal metastasis from ovarian carcinoma...
  3. pmc Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
    Yesim Eralp
    Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Breast Cancer Res 6:R275-83. 2004
    ..The purpose of the present study was to determine whether cytotoxic chemotherapeutic agents administered prior to immunotherapy with gene vaccines could augment the efficacy of the vaccines...
  4. ncbi request reprint Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group
    Yesim Eralp
    Institute of Oncology, University of Istanbul, Capa, Topkapi 34390, Istanbul, Turkey
    Cancer Invest 21:737-43. 2003
    ..039). The results of this study suggest that adjuvant radiotherapy may provide survival benefit in patients with resectable thymoma, regardless of surgical margins...
  5. ncbi request reprint Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix
    Y Eralp
    Department of Medical Oncology, University of Istanbul, Institute of Oncology, Istanbul, Turkey
    Int J Gynecol Cancer 13:497-504. 2003
    ....
  6. doi request reprint Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger
    Yesim Eralp
    Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA
    J Cancer Res Clin Oncol 135:141-8. 2009
    ..The aim of this study is to evaluate the impact of body mass index (BMI) and various prognostic factors on pathologic response and survival in young patients with localized breast cancer...
  7. doi request reprint Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer
    Duygu Derin
    Department of Medical Oncology, Institute of Oncology, Istanbul University
    Cancer Invest 26:671-9. 2008
    ..The aim of this study is to evaluate the prognostic impact of various molecular markers in patients with receptor negative breast cancer...
  8. doi request reprint Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Yesim Eralp
    Department of Medical Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey
    Am J Clin Oncol 36:215-23. 2013
    ....
  9. ncbi request reprint Factors related to recurrence after pathological complete response to postoperative chemotherapy in patients with epithelial ovarian cancer
    Hakan Karagol
    Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
    Tumori 95:207-11. 2009
    ..The goal of this study was to define clinical risk factors for recurrence after complete pathological response to postoperative chemotherapy in patients with epithelial ovarian cancer...
  10. ncbi request reprint Aggressive non-Hodgkin's lymphoma treated at the Institute of Oncology, Istanbul: treatment, outcome, and prognostic factors
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istanbul, Turkey
    Am J Clin Oncol 25:502-8. 2002
    ..In multivariate analyses, patient age, performance status, and treatment response emerged as independent prognostic factors for survival...
  11. doi request reprint Factors affecting the prognosis of breast cancer patients with brain metastases
    Pinar Saip
    Department of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey
    Breast 17:451-8. 2008
    ..Prophylactic cranial radiotherapy may be an effective treatment option for metastatic patients with complete responsive disease and with controlled ErbB-2 positive disease...
  12. ncbi request reprint Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum
    Irfan Cicin
    Department of Medical Oncology, Faculty of Medicine, Trakya University, Turkey
    Gynecol Oncol 108:136-40. 2008
    ..To evaluate the clinicopathological prognostic factors and outcome of chemotherapy in ovarian carcinosarcomas...
  13. ncbi request reprint Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)
    Suleyman Alici
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Am J Clin Oncol 26:358-62. 2003
    ..Oral etoposide has considerable activity with a tolerable toxicity profile for the treatment of platinum-resistant epithelial ovarian cancer...
  14. doi request reprint Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy
    Serkan Keskin
    Department of Medical Oncology, University of Istanbul, Istanbul, Turkey
    Oncology 81:30-8. 2011
    ..Patients with breast cancer with a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) have a better prognosis than patients with residual disease. The aim of the current study was to identify predictors of pCR...
  15. doi request reprint Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors
    Irfan Cicin
    Department of Medical Oncology, Faculty of Medicine, Trakya University, Turkey
    Eur J Obstet Gynecol Reprod Biol 146:210-4. 2009
    ..To evaluate the clinicopathological prognostic features, factors and outcomes of chemotherapy in ovarian yolk sac tumours (YST)...
  16. doi request reprint Association of clinical and pathological variables with survival in thymoma
    Adnan Aydiner
    Department of Medical Oncology, Institute of Oncology, Istanbul University, Capa, Istanbul 34093, Turkey
    Med Oncol 29:2221-8. 2012
    ..Masaoka staging, WHO and MG are major determinants of prognosis in Turkish thymoma patients. Additionally, radiotherapy did not provide survival advantage to stage 2 patients with complete resection...
  17. doi request reprint Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis
    Pinar Saip
    Department of Medical Oncology, Institute of Oncology, Istanbul University, Turkey
    J Neurooncol 93:243-51. 2009
    ..To identify the candidates for prophylactic cranial radiotherapy (PCI) among the patients with early and advanced-stage breast cancer...
  18. ncbi request reprint The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer
    Hakan Karagol
    Department of Medical Oncology, Faculty of Medicine, Trakya University, Turkey
    Med Oncol 24:39-43. 2007
    ..In this study, we evaluated efficacy of tamoxifen in our patients with platinum-resistant epithelial ovarian carcinoma...
  19. doi request reprint Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study
    Adnan Aydiner
    Institute of Oncology, Istanbul University, Turkey
    Clin Lung Cancer 12:286-92. 2011
    ....
  20. ncbi request reprint Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer. Consolidative intraperitoneal cisplatin in ovarian cancer
    Erkan Topuz
    Istanbul University Institute of Oncology, Istanbul, Turkey
    Gynecol Oncol 92:147-51. 2004
    ..The aim of this study is to evaluate the efficacy of intraperitoneal cisplatin as consolidation treatment in epithelian ovarian cancer patients with complete pathologic response following front-line platin-based chemotherapy...
  21. doi request reprint Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer
    Ugur Deligezer
    Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey
    Ann N Y Acad Sci 1137:175-9. 2008
    ..This information might be helpful in evaluating the response of patients to adjuvant systemic therapy...
  22. ncbi request reprint Induction and concurrent chemotherapy with concomitant boost radiotherapy in non-small cell lung cancer
    Ethem Nezih Oral
    Istanbul University, Institute of Oncology, 34390 Capa, Istanbul, Turkey
    Med Oncol 22:367-74. 2005
    ..The response rate and the survival rates achieved with this treatment regimen are particularly noteworthy, especially considering the advanced stage of the patients treated...
  23. doi request reprint A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer
    Ibrahim Yildiz
    Department of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey
    Cancer Chemother Pharmacol 72:437-44. 2013
    ..This study was conducted to determine the clinical significance of serum M30 and M65 in epithelial ovarian cancer (EOC)...
  24. ncbi request reprint Prognostic factors and survival in late adolescent and adult patients with small round cell tumors
    Yesim Eralp
    Department of Medical Oncology, University of Istanbul, Institute of Oncology, Turkey
    Am J Clin Oncol 25:418-24. 2002
    ..017, RR. 15, 95% CI: 1.6; 141.2). Large-scale, multicenter studies are required for a better eval-uation of the nonpediatric age group with small round cell tumors...
  25. ncbi request reprint The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients
    Faruk Tas
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Acta Oncol 44:161-7. 2005
    ..In multivariate analysis, female sex (p=0.0006), high income (p=0.0008), advanced stage at diagnosis (p=0.02), and usage of multiple chemotherapy applications (p=0.03) were determined as independent factors for CAM use...
  26. ncbi request reprint Clinical characteristics of gestational trophoblastic disease at a single institute
    Suleyman Alici
    Institute of Oncology, Istanbul University, Turkey
    Tohoku J Exp Med 197:95-100. 2002
    ..And, our report confirms that the alternating EMA/CO regimen is a well-tolerated and effective combination for the treatment of women with high-risk GTD...
  27. pmc Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
    Fatma Sen
    aDepartment of Medical Oncology, Institute of Oncology bDepartment of Radiation Oncology cDepartment of Thoracic Surgery dDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Medicine (Baltimore) 95:e4280. 2016
    ..6%, P = 0.024).Concurrent chemoradiotherapy with EP may provide more favorable outcomes than DP and with an acceptable safety profile. ..
  28. pmc Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
    Adnan Aydiner
    From the Department of Medical Oncology AA, FS, RC, Ye, PS Department of Radiation Oncology MT, MF, SK Surgical Oncology Unit, Institute of Oncology HK Department of Pathology SO, EY and Surgical Oncology Unit, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey MM, AI
    Medicine (Baltimore) 94:e2341. 2015
    ..8, P = 0.009).MBC is significantly correlated with worse PFS and OS compared with TNBC. Patients with MBC are resistant to conventional CT agents, and more efficient treatment regimens are required...
  29. ncbi request reprint Multifocal breast cancer in women < or =35 years old
    Jennifer K Litton
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:1445-50. 2007
    ..The relation that multifocality at diagnosis had to survival in women < 35 years of age was evaluated...
  30. ncbi request reprint Prognostic factors in localized soft-tissue sarcomas
    Esra Kaytan
    Department of Radiation Oncology, University of Istanbul, Institute of Oncology, Istanbul, Turkey
    Am J Clin Oncol 26:411-5. 2003
    ..Again, development of metastases and age were the most important prognostic factors in operable soft-tissue sarcomas...
  31. doi request reprint Ovarian carcinoma with simultaneous breast and rectum metastases
    Duygu Derin
    Institute of Oncology, Istanbul Faculty of Medicine, Istanbul University, Turkey
    Onkologie 31:200-2. 2008
    ..Metastatic involvement of the breast and the rectum from ovarian carcinoma are very rare events...
  32. doi request reprint Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
    Ugur Deligezer
    Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey
    Clin Chem Lab Med 46:311-7. 2008
    ..Here, we investigated the dynamics of serum DNA levels and the size distribution of cf-DNA during adjuvant chemotherapy of patients with breast cancer (n=73)...
  33. ncbi request reprint Prognostic factors in localized aggressive non-Hodgkin's lymphoma
    Suleyman Alici
    Institute of Oncology, Istanbul University, Istambul, Turkey
    Am J Clin Oncol 26:1-5. 2003
    ..These factors need to be evaluated for analyzing the outcome of treatment and to identify better therapeutic strategies...
  34. ncbi request reprint Anemia in oncology practice: relation to diseases and their therapies
    Faruk Tas
    Institute of Oncology, University of Istanbul, Istanbul, Turkey
    Am J Clin Oncol 25:371-9. 2002
    ..The mechanisms underlying the propensity for a higher risk of pretreatment anemia in patients with malignant disorders and its influence on the outcome has to be elucidated by further population-based and molecular studies...